‹ ›
MYP_095269
← PREVIOUS NEXT → BACK
Basic Information
CPXV012
Anticancer ▸ Cytotoxic anticancer activity ▸ Cytotoxic
Antimicrobial
Antiviral
Antiviral ▸ Anti-Hepatitis virus ▸ Anti-HBV
Antiviral ▸ Anti-Herpesvirus ▸ Anti-HSV
Antiviral ▸ Anti-HIV ▸ Anti-HIV-1
Antiviral ▸ Antiviral mechanism ▸ Viral replication inhibition
Enzyme modulation ▸ Enzyme inhibition ▸ Infection inhibition
Toxicity / Safety ▸ Cytotoxicity ▸ Cytotoxic
Venom / Toxin ▸ General toxin ▸ Cytotoxic
Standard
34 amino acids
C204H303N55O48S2
Standard
Sequence
QEGISRFKICPYHWYKQHMSLLFRRYYHKLDSII
Physicochemical Analysis
4358.06 Da
9.65
4.01
3.63
0.1179
-0.59
0.67
-0.08
71.96
80.29
0.2059
11460.00
11460.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
1682.81
-8.54
62.0
57.0
142.0
309.0
12.0
35.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0255433 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antimicrobial Antiviral Cytotoxic
μg/mL
200 μg/mL
Cytotoxicity
PMID32872420 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/32872420/
RECORD: Rec_0270958 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Protein-derived synthetic peptide
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antiviral Anti-HBV
Hepatitis B virus (HBV) | HepRG cells
100 μg/mL
% inhibition
Mammalian: 0.8 h; Yeast: 10 min; E. coli: >10 h
PaperA Broad-Spectrum Antiviral Peptide Blocks Infection of Viruses by Binding to Phosphatidylserine in the Viral Envelope. | Luteijn RD, Praest P, Thiele F, Sadasivam SM, Singethan K, Drijfhout JW, Bach C, de Boer SM, Lebbink RJ, Tao S, Helfer M, Bach NC, Protzer U, Costa AI, Killian JA, Drexler I, Wiertz EJHJ. | Cells. 2020 Aug 29;9(9):1989. | DOI:10.3390/cells9091989 | PMID:32872420 PMID32872420 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/32872420/
RECORD: Rec_0282426 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antimicrobial Antiviral
Rift Valley fever virus(RVFV)
PMID32872420 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/32872420/
RECORD: Rec_0285004 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Protein-derived synthetic peptide
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antiviral Anti-HSV Infection inhibition
Herpes simplex virus-1 (HSV-1)
150 μg/mL
% inhibition
Mammalian: 0.8 h; Yeast: 10 min; E. coli: >10 h
PaperA Broad-Spectrum Antiviral Peptide Blocks Infection of Viruses by Binding to Phosphatidylserine in the Viral Envelope. | Luteijn RD, Praest P, Thiele F, Sadasivam SM, Singethan K, Drijfhout JW, Bach C, de Boer SM, Lebbink RJ, Tao S, Helfer M, Bach NC, Protzer U, Costa AI, Killian JA, Drexler I, Wiertz EJHJ. | Cells. 2020 Aug 29;9(9):1989. | DOI:10.3390/cells9091989 | PMID:32872420 PMID32872420 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/32872420/
RECORD: Rec_0292812 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antimicrobial Antiviral
PMID32872420 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/32872420/
FIRST PREV 1 2 3 NEXT LAST
Showing 5 records on this page · Page 2 of 3